179 related articles for article (PubMed ID: 1334594)
1. Recurrent hepatitis C virus infection after liver transplantation.
Arnold JC; Kraus T; Otto G; Müller HM; Hofmann W; Gmelin K; Goeser T; Kommerell B; Theilmann L
Transplant Proc; 1992 Dec; 24(6):2646-7. PubMed ID: 1334594
[No Abstract] [Full Text] [Related]
2. [Recurrent and acquired hepatitis C virus infection in patients after liver transplantation].
Theilmann L; Goeser T
Z Gastroenterol; 1993 Feb; 31(2):161-2. PubMed ID: 8465560
[No Abstract] [Full Text] [Related]
3. [Long-term prognosis after liver transplantation for hepatitis C virus-induced liver disease].
Herbay A; Niederau C
Z Gastroenterol; 1995 Aug; 33(8):468-9. PubMed ID: 7483742
[No Abstract] [Full Text] [Related]
4. [Risks and prevention in orthotopic liver transplantation and persistent infection with hepatitis type B and type delta viruses].
Hopf U; Neuhaus P; König V; Bauditz J; Küther S; Schmidt CA; Steffen R; Blumhardt G; Bechstein WO; Neuhaus R
Z Arztl Fortbild (Jena); 1992 Sep; 86(17):861-8. PubMed ID: 1413903
[No Abstract] [Full Text] [Related]
5. Recurrent hepatitis C virus infection after liver transplantation--long-term follow-up with respect to the HCV genotypes/subtypes.
Arnold JC; Töx U; Goeser T; Otto G; Müller HM; Hofmann WJ; Stremmel W; Theilmann L
Z Gastroenterol; 1997 Apr; 35(4):255-61. PubMed ID: 9163889
[TBL] [Abstract][Full Text] [Related]
6. [Further progress in liver transplantation].
Demling L
Fortschr Med; 1991 Feb; 109(6):17. PubMed ID: 1646148
[No Abstract] [Full Text] [Related]
7. De novo hepatocellular carcinoma in a liver allograft associated with recurrent hepatitis B.
Torbenson M; Grover D; Boitnott J; Klein A; Molmenti E
Transplant Proc; 2005 Jun; 37(5):2205-6. PubMed ID: 15964379
[TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal stromal tumor in a liver transplant recipient.
Saidi RF; Sepehr A; Cosimi AB; Hertl M
Transplantation; 2008 May; 85(9):1363. PubMed ID: 18475199
[No Abstract] [Full Text] [Related]
9. [Natural history of HCV infection].
Trinchet JC
Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B144-53. PubMed ID: 12180282
[No Abstract] [Full Text] [Related]
10. Early hepatic stellate cell activation is associated with advanced fibrosis after liver transplantation in recipients with hepatitis C.
Russo MW; Firpi RJ; Nelson DR; Schoonhoven R; Shrestha R; Fried MW
Liver Transpl; 2005 Oct; 11(10):1235-41. PubMed ID: 16184580
[TBL] [Abstract][Full Text] [Related]
11. [Long-term prognosis of chronic B and C viral hepatitis].
Ohlen J; Liegl JM; Selmair H
Leber Magen Darm; 1995 Sep; 25(5):205-10. PubMed ID: 7500807
[TBL] [Abstract][Full Text] [Related]
12. Recurrence of diseases following orthotopic liver transplantation.
Kotlyar DS; Campbell MS; Reddy KR
Am J Gastroenterol; 2006 Jun; 101(6):1370-8. PubMed ID: 16771963
[TBL] [Abstract][Full Text] [Related]
13. [A patient with cryoglobulinemia and hepatitis C].
Wallnöfer de Jong AG; Conzelmann M; Steiger U
Praxis (Bern 1994); 1997 Oct; 86(43):1703-7. PubMed ID: 9432696
[TBL] [Abstract][Full Text] [Related]
14. HCV histological recurrence and survival following liver transplantation in patients with and without hepatocellular carcinoma.
De Martin E; Senzolo M; Boninsegna S; Guido M; Masier A; Germani G; Tomat S; Brolese A; Neri D; Cillo U; Gambato M; Russo FP; Farinati F; Burra P
Transplant Proc; 2008; 40(6):1974-5. PubMed ID: 18675104
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up in hepatitis C patients with respect to immunosuppression.
Mueller AR; Platz KP; Berg T; Fukomoto T; Guckelberger O; Neuhaus R; Bechstein WO; Hopf U; Lobeck H; Neuhaus P
Transplant Proc; 1996 Dec; 28(6):3241-2. PubMed ID: 8962255
[No Abstract] [Full Text] [Related]
16. Hepatocellular carcinoma: Can it be considered a controversial indication for liver transplantation in centers with high rates of hepatitis C?
Moya A; Berenguer M; Aguilera V; Juan FS; Nicolás D; Pastor M; López-Andujar R; Rayón M; Orbis F; Mora J; De Juan M; Carrasco D; Vila JJ; Prieto M; Berenguer J; Mir J
Liver Transpl; 2002 Nov; 8(11):1020-7. PubMed ID: 12424715
[TBL] [Abstract][Full Text] [Related]
17. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
[TBL] [Abstract][Full Text] [Related]
18. Surgical management of hepatocellular carcinoma.
Lotze MT
Gastroenterol Clin North Am; 1987 Dec; 16(4):613-26. PubMed ID: 2831154
[TBL] [Abstract][Full Text] [Related]
19. Retransplantation for de novo hepatocellular carcinoma in a liver allograft with recurrent hepatitis B cirrhosis 14 years after primary liver transplantation.
Kita Y; Klintmalm G; Kobayashi S; Yanaga K
Dig Dis Sci; 2007 Dec; 52(12):3392-3. PubMed ID: 17404871
[No Abstract] [Full Text] [Related]
20. Morphologic features of hepatitis C recurrence in patients after orthotopic liver transplantation-preliminary analysis of our case observations.
Ziarkiewicz-Wróblewska B; Górnicka B; Ołdakowska-Jedynak U; Bogdańska M; Wróblewski T; Morton M; Ziółkowski J; Paczek L; Krawczyk M; Wasiutyński A
Transplant Proc; 2006; 38(1):226-30. PubMed ID: 16504709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
